Go Pro

Keros Therapeutics (KROS) Stock Chart & Stock Price History

Keros Therapeutics logo
$11.19 -0.17 (-1.50%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$11.02 -0.17 (-1.53%)
As of 09/18/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Keros Therapeutics Stock Price Performance

The Keros Therapeutics (KROS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 28.08%, with a year-to-date return of -45.04%. In the past month, the stock has increased 2.19%, reflecting recent market activity.

As of the latest close, Keros Therapeutics traded at $11.19 with a market cap of $221.86 million and volume of 302,476 shares. Five years ago, the stock traded at $29.27, representing a 61.77% decrease over that period. At the time, it had a market cap of $683.10 million and a volume of 139,299 shares.

Receive KROS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+0.18%
1 Month
Performance
+2.19%
3 Month
Performance
+4.73%
Year-To-Date
Performance
-45.04%
1 Year
Performance
-28.08%
5 Year
Performance
-61.77%

KROS Stock Chart for Sunday, September, 20, 2026

Keros Therapeutics Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/18/2026$11.36$11.19
-1.50%
$11.40$11.10302,476 shs$221.86 million
09/17/2026$10.74$11.36
+5.77%
$11.39$10.83274,089 shs$225.27 million
09/16/2026$11.17$10.74
-3.85%
$11.23$10.70273,562 shs$212.97 million
09/15/2026$11.21$11.17
-0.36%
$11.21$10.72199,981 shs$221.47 million
09/14/2026$11.08$11.21
+1.17%
$11.34$10.98342,163 shs$222.29 million
09/11/2026$11.17$11.08
-0.81%
$11.34$11.03143,825 shs$219.72 million
09/10/2026$11.31$11.17
-1.24%
$11.20$11.00128,791 shs$221.50 million
09/09/2026$11.17$11.31
+1.25%
$11.82$11.21188,506 shs$224.24 million
09/08/2026$11.32$11.17
-1.33%
$11.31$10.9873,036 shs$221.50 million
09/07/2026$11.32$11.32$11.40$11.0265,635 shs$224.48 million
09/04/2026$11.11$11.32
+1.89%
$11.40$11.0265,635 shs$224.48 million
09/03/2026$11.23$11.11
-1.07%
$11.32$10.92148,712 shs$220.31 million
09/02/2026$11.07$11.23
+1.45%
$11.49$10.9797,968 shs$222.66 million
09/01/2026$11.08$11.07
-0.09%
$11.13$10.8396,241 shs$219.52 million
08/31/2026$11.03$11.08
+0.45%
$11.20$10.76179,962 shs$219.72 million
08/28/2026$11.23$11.03
-1.78%
$11.16$10.58328,287 shs$218.73 million
08/27/2026$11.12$11.23
+0.99%
$11.48$11.01127,576 shs$222.66 million
08/26/2026$11.68$11.12
-4.79%
$11.66$11.08113,585 shs$220.51 million
08/25/2026$10.78$11.68
+8.35%
$11.71$10.83200,322 shs$231.61 million
08/24/2026$11.03$10.78
-2.27%
$11.12$10.72217,075 shs$213.74 million
08/21/2026$10.95$11.03
+0.73%
$11.09$10.81157,507 shs$218.69 million
08/20/2026$11.10$10.95
-1.35%
$11.10$10.55203,071 shs$217.14 million
08/19/2026$10.61$11.10
+4.62%
$11.17$10.63152,154 shs$220.11 million

This page (NASDAQ:KROS) was last updated on 9/18/2026 by MarketBeat.com Staff.
From Our Partners